Title : Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease - Wallentin_2016_J.Am.Heart.Assoc_5_ |
Author(s) :
Wallentin L , Held C , Armstrong PW , Cannon CP , Davies RY , Granger CB , Hagstrom E , Harrington RA , Hochman JS , Koenig W , Krug-Gourley S , Mohler ER, 3rd , Siegbahn A , Tarka E , Steg PG , Stewart RA , Weiss R , Ostlund O , White HD |
Ref :
J Am Heart Assoc , 5 : , 2016 |
Abstract : Wallentin_2016_J.Am.Heart.Assoc_5_ |
ESTHER : Wallentin_2016_J.Am.Heart.Assoc_5_ |
PubMedSearch : Wallentin_2016_J.Am.Heart.Assoc_5_ |
PubMedID: 27329448 |